These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11036831)

  • 21. Cognitive impairment in a Colombian cohort of patients with systemic lupus erythematosus: A cross-sectional study.
    Medina YF; Rivera MR; Duarte LK; Rodriguez-Plata CM; De León ER; Rodríguez Martínez SC
    Lupus; 2024 Sep; 33(10):1025-1033. PubMed ID: 39279055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychological patterns in systemic lupus erythematosus patients with depression.
    Kozora E; Arciniegas DB; Zhang L; West S
    Arthritis Res Ther; 2007; 9(3):R48. PubMed ID: 17504538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic lupus erythematosus impairs memory cognitive tests not affected by depression.
    Calderón J; Flores P; Babul M; Aguirre JM; Slachevsky A; Padilla O; Scoriels L; Henríquez C; Cárcamo C; Bravo-Zehnder M; González A; Massardo L
    Lupus; 2014 Sep; 23(10):1042-53. PubMed ID: 24879658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
    Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus.
    Utset TO; Fink J; Doninger NA
    J Rheumatol; 2006 Mar; 33(3):531-8. PubMed ID: 16511923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
    Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF
    Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.
    Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF
    Lupus; 2013 Aug; 22(9):873-84. PubMed ID: 23846230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
    Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
    Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocognitive impairment in corticosteroid-naive patients with active systemic lupus erythematosus: a prospective study.
    Nishimura K; Omori M; Katsumata Y; Sato E; Gono T; Kawaguchi Y; Harigai M; Mimura M; Yamanaka H; Ishigooka J
    J Rheumatol; 2015 Mar; 42(3):441-8. PubMed ID: 25593228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus.
    Mikdashi J; Krumholz A; Handwerger B
    Neurology; 2005 Jun; 64(12):2102-7. PubMed ID: 15985581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of severe neuropsychiatric manifestations on short-term damage in systemic lupus erythematosus.
    Fragoso-Loyo HE; Sánchez-Guerrero J
    J Rheumatol; 2007 Jan; 34(1):76-80. PubMed ID: 17143970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are cognitive and olfactory dysfunctions in neuropsychiatric lupus erythematosus dependent on anxiety or depression?
    Cavaco S; Martins da Silva A; Santos E; Coutinho E; Marinho A; Moreira I; Gonçalves A; Pinto C; Teixeira-Pinto A; Vasconcelos C
    J Rheumatol; 2012 Apr; 39(4):770-6. PubMed ID: 22382338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients.
    Zhou HQ; Zhang FC; Tian XP; Leng XM; Lu JJ; Zhao Y; Tang FL; Zhang X; Zeng XF; Zhang ZL; Zhang W; Dong Y
    Lupus; 2008 Feb; 17(2):93-9. PubMed ID: 18250131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB; Ibañez D; Jerome D; Gladman DD
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges of Diagnosing Cognitive Dysfunction With Neuropsychiatric Systemic Lupus Erythematosus in Childhood.
    AlE'ed A; Vega-Fernandez P; Muscal E; Hinze CH; Tucker LB; Appenzeller S; Bader-Meunier B; Roth J; Torrente-Segarra V; Klein-Gitelman MS; Levy DM; Roebuck-Spencer T; Brunner HI;
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1449-1459. PubMed ID: 27992660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of neuropsychological impairment and vocational outcomes in systemic lupus erythematosus and multiple sclerosis patients.
    Covey TJ; Shucard JL; Shucard DW; Stegen S; Benedict RH
    J Int Neuropsychol Soc; 2012 May; 18(3):530-40. PubMed ID: 22410107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuropsychiatric systemic lupus erythematosus (1st part). Cases definitions and diagnosis and treatment of central nervous system and psychiatric manifestations of systemic lupus erythematosus].
    Lefèvre G; Zéphir H; Warembourg F; Michelin E; Pruvo JP; Hachulla E; Semah F; Dubucquoi S; Lenfant P; Vermersch P; Hatron PY; Prin L; Launay D
    Rev Med Interne; 2012 Sep; 33(9):491-502. PubMed ID: 22579860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE.
    Ibañez D; Gladman DD; Urowitz MB
    J Rheumatol; 2005 May; 32(5):824-7. PubMed ID: 15868616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral computed tomography and electroencephalography compared with neuropsychological findings in systemic lupus erythematosus.
    Waterloo K; Omdal R; Jacobsen EA; Kløw NE; Husby G; Torbergsen T; Mellgren SI
    J Neurol; 1999 Aug; 246(8):706-11. PubMed ID: 10460449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.